An EPIC-STEMI trial study was conducted to compare an inhibitor of pro-protein convertase subtilisin/kexin type 9 (PCSK9) alirocumab with sham-control among patients having Myocardial Infraction due to ST-segment Elevation...
Most Recent Articles
Efficacy and Safety of Fractional Flow Reserve (FFR) Strategy for Revascularization
A trial study was carried out to check the efficacy and safety of routine systematic measurement of fractional flow reserve (FFR) for all vessels with the caliber of revascularization. For this purpose, 1100 patients were...
VISUALIZED: Use of Polypill Strategy for the Prevention of Cardiovascular Disease In the Elderly
Read further: Use of Polypill Strategy for the Prevention of Cardiovascular Disease In the Elderly
Use of Polypill Strategy for the Prevention of Cardiovascular Disease In the Elderly
The research was carried out to measure the effectiveness of the polypill strategy compared to usual care in patients with myocardial infarction within the last 6 months. For this purpose, a parallel and randomized study was...
2022 ESC Guidelines on Cardio-Oncology
Guidelines on cardio-oncology are the result of the immense work of the European Society of Cardiology (ESC), the European Society for Therapeutic Radiology and Oncology, the European Hematology Association, and the International...